To Get Help Now
Click Here
 
Today's Date:

NuvaRing Facing Escalating Number of Lawsuits

AddThis Social Bookmark Button

Aimee L. Flynn of Pennsylvania is the latest person to file a lawsuit against Merck & Co., over the NuvaRing contraceptive device. The lawsuit, filed in the U.S. District Court for the District of New Jersey, said that Flynn used NuvaRing from October 2008 to February 2010, when she suffered a stroke.

According to the lawsuit, Merck & Co., Akzo Nobel NV, Organon Pharmaceuticals, and Schering-Plough Corporation, all failed to warn physicians and consumers regarding the increased risk of blood clots from side effects caused by NuvaRing. In the complaint, the defendants are accused of breach of warranty, negligence, strict liability, and fraud.

The FDA published a study in 2011 that found that the risk of suffering blood clots by women who used NuvaRing was 56 percent higher than older birth control pills. The risks include pulmonary embolism, arterial thrombosis, including heart attack and stroke, and Deep Vein Thrombosis (DVT).

The lawsuit seeks compensatory and punitive damages. All NuvaRing lawsuits filed in the United States have been consolidated as part of an MDL, and Flynn’s lawsuit is expected to be transferred to the MDL.

breakinglawsuitnews.com disclaimer: This article: NuvaRing Facing Escalating Number of Lawsuits was posted on Wednesday, February 22nd, 2012 at 9:24 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Comments are closed.